We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





CDC Provides Test Protocol for Novel Coronavirus

By LabMedica International staff writers
Posted on 11 Feb 2020
The US Centers for Disease Control and Prevention (Atlanta GA, USA) has publicly posted its assay for novel coronavirus 2019-nCoV and is now developing the test into kits. More...
The CDC diagnostic test is a reverse transcriptase real-time PCR (rRT-PCR) assay developed for respiratory and blood serum samples. The protocol to make the assay has been made publicly available.

Specifically, if a person is identified with a travel history or contact that could have led to exposure, and also has a fever and respiratory illness, typically a health department is alerted. Through discussion with CDC, it is determined whether diagnostics are merited, and a sample is sent to CDC. All told 260 people in 26 states are currently or have been investigated for 2019-nCoV infection. To date, the agency has screened 2,400 people at five selected USA ports of entry. It is continuing to assess the public health situation as it evolves, she said, adding that CDC will likely be providing guidance on potential additional travel restrictions in the next few days.

The protocol specifies primers and probes, provides guidance on sample preparation, and advises performing rRT-PCR on the AB 7500 Fast DX thermal cycler (Thermo Fisher Scientific, Waltham, MA, USA). The agency's interim guidance for 2019-nCoV testing indicates biosafety precautions of using RNase Away or freshly prepared solution of 10% bleach for cleanup. In addition to the 11 cases confirmed positive in the USA using the rRT-PCR test, and167 cases confirmed negative, there are also 82 cases pending, which the agency said on its website includes specimens received and awaiting testing, as well as specimens en route to CDC.

Nancy Messonnier, MD, the director of the National Center for Immunization and Respiratory Diseases, said, “The time lag between the decision that a patient needs further laboratory testing and a test result is somewhere around a day, depending on geographically where that patient is being seen and how we can most efficiently ship. This is essentially a blueprint to make the test. Currently we are refining the use of this test so we can provide optimal guidance to states and laboratorians on how to use it.”

Related Links:
US Centers for Disease Control and Prevention
Thermo Fisher Scientific



Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Molecular Diagnostics

view channel
Image: Spatial profiling of muscle-invasive bladder cancer reveals how distinct tumor cell states are organized within individual tumors (Image Credit: Shutterstock)

Spatial Map Guides Treatment Selection in Muscle-Invasive Bladder Cancer

Muscle-invasive bladder cancer is clinically heterogeneous, with patients often responding very differently to therapy. Existing biomarkers do not fully explain these disparities, limiting precision treatment... Read more

Microbiology

view channel
Image: Burkholderia pseudomallei is a soil-dwelling bacterium that causes melioidosis, a severe and potentially fatal infection that remains difficult to diagnose (Image Credit: Gavin Koh/Wikimedia Commons, CC BY-SA 4.0)

Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread

Melioidosis, a potentially fatal infection caused by Burkholderia pseudomallei, remains difficult to recognize because its symptoms can mimic tuberculosis and other illnesses. The disease is considered... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.